Gustavo Moura Bruder

Gustavo Moura Bruder

Auto-generated profile, based on publicly available information

Gustavo Moura Bruder

Universidade de Rio Verde

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2022 in E-Acadêmica
Verified
Journal Article
Open access
PDF file
ACAna Gabriella Costa Curado
Ana Gabriella Costa Curado
GBGustavo Moura Bruder
Gustavo Moura Bruder
BCBeatriz Lima da Costa
Beatriz Lima da Costa
GGGiovanna de Melo Gasques
Giovanna de Melo Gasques
ICIsabella Ramos Cruz
Isabella Ramos Cruz
HPHallamark Alvarez Lemos Portella
Hallamark Alvarez Lemos Portella
Introduction: COVID-19 is a disease caused by the new coronavirus, called SARS-CoV-2, an RNA virus, which initially emerged in Wuhan, China, in December 2019. asymptomatic and severe conditions, especially in patients with previous pathologies, such as patients with rheumatologic diseases. Method: The work was carried out in the form of an integrative review of the literature, it aimed to bring together the studies and identify the possible complications that rheumatic diseases would have in patients who contract COVID-19. Results/Discurssion: In view of the current health situation, the analysis of the studies showed that both COVID-19 and rheumatic diseases present a pathogenic cytokine, among the diseases rheumatoid arthritis, lupus erythematosus and primary Sjogren's spindrome. Conclusion: The work presented difficulties during its production, the greatest difficulty was the lack of literature that addresses the subject. Therefore, patients with DRIM must be evaluated individually and dimensioned for each clinical situation, especially in situations where COVID is suspected, in these cases the rheumatologist has a fundamental role in decision-making.